David F. Hale, Director at Somaxon Pharmaceuticals, Inc. (SOMX), sold 116,493 shares at $2.68 ($289K) on 2010-12-01, disclosed to the SEC on 2010-12-03.
Scheduled sale ($289k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 8,050 | $0 | 0.0% |
| 2 | $0.00 | 550 | $0 | 0.0% |
| 3 | $2.68 | 107,893 | $289K | 100.0% |
| Total | $2.48 avg | 116,493 | $289K | 100% |
| Filing → |
| ONCT | SELL | 2021-07-02 | $17K | — | Filing → |
| BIOC | SELL | 2020-06-12 | $645 | — | Filing → |
| BIOC | BUY | 2016-10-21 | $200K | — | Filing → |